MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-06-0034341
Manuel Pharmaceuticals Private Limited
Manuel Pharmaceuticals Private Limited - chemicals and materials in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹3.5 Cr
▼ 1% YoY
Net profit · FY 2025
₹9.2 Lakh
Net margin 2.6%
EBITDA · FY 2025
₹22.81 Lakh
EBITDA margin 6.5%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹66.5 Lakh
Secured borrowings
Company age
15 yrs
Est. 2011
Directors on board
2
As per MCA filings
About Manuel Pharmaceuticals Private Limited
Data last updated:
Manuel Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the industrial chemicals segment of the chemicals and materials sector. It was incorporated on 19 February 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51397DL2011PTC214417. Its GSTIN is 09AAHCM2128D1ZQ (Uttar Pradesh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Pankaj Agarwal and Sakshi Agarwal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No. 61 Dipni Apartments Road No. 44 Pitam Pur, A, New Delhi, Delhi, India – 110034.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.5 Cr, a decline of 1% compared to the previous year. For the same year it recorded a net profit of ₹9.2 Lakh (net margin 2.6%) and EBITDA of ₹22.81 Lakh (EBITDA margin 6.5%). Revenue has declined at a compounded annual rate (CAGR) of 5% over three years.
As per MCA filings, the company has open charges of ₹66.5 Lakh on record.
Manuel Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-06-0034341). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U51397DL2011PTC214417
Registration Number 214417
Incorporation Date 19 February 2011
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-06-0034341
Recognitions & Rankings of Manuel Pharmaceuticals
Contact details
Manuel Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressFlat No. 61 Dipni Apartments Road No. 44 Pitam Pur, A, New Delhi, Delhi, India – 110034
- IndustryChemicals and Materials, Industrial Chemicals
To see the full contact details of Manuel Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Manuel Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Manuel Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Manuel Pharmaceuticals Private Limited, buy the company report.
Financials of Manuel Pharmaceuticals Private Limited
FY 2025 filings availableManuel Pharmaceuticals Private Limited reported revenue of ₹3.5 Cr (down 1% YoY) for FY 2025.
Revenue · FY 2025
₹3.5 Cr ▼ 1%
Net profit · FY 2025
₹9.2 Lakh margin 2.6%
EBITDA · FY 2025
₹22.81 Lakh margin 6.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 1%
3 years · compounded
▼ 5%
EBITDA CAGR growth
1 year
▼ 10%
3 years · compounded
▲ 2%
5 years · compounded
▲ 1%
Revenue has declined at a compounded annual rate (CAGR) of 5% over three years, including a 1% fall in the latest year. EBITDA fell 10% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹22.81 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹9.2 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.5% | ||||
| Net Profit Margin | 2.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Manuel Pharmaceuticals Private Limited, buy the company report.
Board of directors of Manuel Pharmaceuticals Private Limited
Manuel Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pankaj Agarwal | Director | 19 Feb 2011 | 15 Years 8 Months | Current |
| Sakshi Agarwal | Additional Director | 27 Mar 2025 | 1 Years 7 Months | Current |
Auditor
Manuel Pharmaceuticals Private Limited is audited by RISHI KAPOOR & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RISHI KAPOOR & CO | FY 2020 | 006615C |
Shareholding
The shareholding of Manuel Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Manuel Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹66.5 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 02 Apr 2022 | 100584611 | Hdfc Bank Limited | ₹66.5 Lakh | Open |
To see the full charge records of Manuel Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Manuel Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Manuel Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Manuel Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAHCM2128D1ZQ | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Manuel Pharmaceuticals Private Limited, buy the company report.
Recent activity
Manuel Pharmaceuticals Private Limited has 3 board changes on record since 2011: 2 appointments and 1 cessation. The latest: Naveen Agarwal ceased to be Director on 27 Mar 2025.
AGM
Manuel Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Manuel Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Ceased
Naveen Agarwal ceased to be Director.
Appointed
Sakshi Agarwal was appointed as Additional Director.
Charges
A charge with Hdfc Bank Limited of Rs. 66.50 Lakh registered on 02 Apr 2022 with Charge ID 100584611 was modified on 27 Sep 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 66.50 Lakh with Charge ID 100584611 was registered on 02 Apr 2022.
Appointed
Pankaj Agarwal was appointed as Director.
Incorporation
19 Feb 2011
Manuel Pharmaceuticals Private Limited was registered on 19 Feb 2011 with Roc Delhi Ii & aged 15 years 8 months as per MCA records.
Frequently asked questions
Manuel Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in industrial chemicals, within the chemicals and materials industry. It was incorporated on 19 February 2011 (15+ years old) and is registered under CIN U51397DL2011PTC214417.
Manuel Pharmaceuticals has 2 current directors:
- Pankaj Agarwal - Director
- Sakshi Agarwal - Additional Director
The latest financial statements of Manuel Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Manuel Pharmaceuticals is 09AAHCM2128D1ZQ, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Manuel Pharmaceuticals is U51397DL2011PTC214417. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Manuel Pharmaceuticals was incorporated on 19 February 2011, making it 15+ years old. It is registered with the Registrar of Companies, Delhi.
Naveen Agarwal ceased to be Director on 27 Mar 2025. Sakshi Agarwal was appointed as Additional Director on 27 Mar 2025. Pankaj Agarwal was appointed as Director on 19 Feb 2011.
Yes, Manuel Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-06-0034341).
The registered office of Manuel Pharmaceuticals is at Flat No. 61 Dipni Apartments Road No. 44 Pitam Pur, A, New Delhi, Delhi, India – 110034.
Manuel Pharmaceuticals operates in the chemicals and materials industry, in the industrial chemicals segment.